Certified Hospice and Palliative Assistant (CHPNA) Practice Test

Which statement is true regarding haloperidol?

1. It lowers the seizure threshold

2. It can be used to treat anxiety

3. It does not lower the seizure threshold

4. It is ineffective for mood stabilization

The correct answer is: It does not lower the seizure threshold

Haloperidol is an antipsychotic medication primarily used in the treatment of various psychiatric disorders, such as schizophrenia and acute psychosis. It is known for its calming effects and is often utilized in managing agitation and severe behavioral disturbances. Importantly, haloperidol does not lower the seizure threshold, making it a safer option for individuals with a history of seizures or those who are at risk for seizures. Understanding this characteristic is essential, especially in a hospice and palliative care context where medication management must consider the holistic needs and underlying health conditions of patients. The lack of seizure threshold lowering means that haloperidol can be used cautiously in patients who may be prone to seizures, thereby assisting with symptom management without exacerbating that risk. Other statements, such as its use for anxiety, are not typically accurate as haloperidol is not primarily indicated for anxiety management. While it may have sedative properties that could potentially help with anxiety in some cases, it is not recommended for that purpose in clinical practice. Similarly, statements regarding its effectiveness for mood stabilization are more nuanced in that haloperidol is not the primary treatment for mood disorders, which are better managed with other classes of medications. Therefore, the true aspect of haloperidol revolves around its safety profile